Surf Bio, a preclinical biopharmaceutical company, utilizes an innovative biotechnology platform to create improved therapeutic options for diabetes, oncology, infectious diseases, gene therapy, and more. Founded by the creators of Bigfoot Biomedical and Mode AGC, Surf Bio aims to bring to market a pioneering drug stabilization technology developed in the Appel Lab. This technology is geared towards reducing refrigeration need...
Surf Bio, a preclinical biopharmaceutical company, utilizes an innovative biotechnology platform to create improved therapeutic options for diabetes, oncology, infectious diseases, gene therapy, and more. Founded by the creators of Bigfoot Biomedical and Mode AGC, Surf Bio aims to bring to market a pioneering drug stabilization technology developed in the Appel Lab. This technology is geared towards reducing refrigeration needs, facilitating a shift from IV to subcutaneous therapy, and introducing innovative pharmaceutical formulations across various therapeutic domains.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.